C
Pharming Group N.V. PHAR
$16.24 $0.030.15% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024
Total Cash And Short-Term Investments -2.25% 7.14% -20.62%
Total Receivables 4.09% -5.71% 32.10%
Inventory -10.45% 5.13% 5.92%
Prepaid Expenses -- -- --
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets -- -- --
Total Current Assets -1.33% 4.27% -8.74%

Total Current Assets -1.33% 4.27% -8.74%
Net Property, Plant & Equipment -21.30% -0.19% -3.57%
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles -9.03% 0.79% -2.53%
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets -16.29% -5.52% 9.02%
Total Assets -6.00% 2.30% -5.83%

Total Accounts Payable -86.09% -0.45% 6.50%
Total Accrued Expenses -- -- --
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current -0.14% 3.31% -94.98%
Total Finance Division Other Current Liabilities -- -- --
Total Other Current Liabilities -- -- --
Total Current Liabilities -7.56% -0.12% -61.44%

Total Current Liabilities -7.56% -0.12% -61.44%
Long-Term Debt -15.14% 5.47% --
Short-term Debt -- -- --
Capital Leases -2.94% 0.19% -2.49%
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities -- -- --
Total Liabilities -10.41% 2.43% -17.28%

Common Stock & APIC 0.39% 0.05% 1.49%
Retained Earnings -7.02% 1.69% 51.03%
Treasury Stock & Other -- -- --
Total Common Equity -2.10% 2.20% 7.28%

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible -- -- --
Preferred Stock, Others -- -- --
Total Preferred Equity -- -- --

Total Common Equity -2.10% 2.20% 7.28%
Total Preferred Equity -- -- --
Total Minority Interest -- -- --
Total Equity -2.10% 2.20% 7.28%